Indo US Bio-Tech (INDOUS) Share Price Falls 8.33%: What the Latest Move Shows
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Indo US Bio-Tech Share Price fell 8.33% to Rs 66, and the company’s market capitalisation stood at Rs 144.37 crore as of 21 October 2026 at 11:53:17 AM IST. The latest UniVest data places this as a clear price fall for a Micro Cap stock, with the move happening after an opening at Rs 72 and a price band that stretched from Rs 72 to Rs 65. Indo US Bio-Tech Share Price is therefore drawing attention for its intraday weakness rather than for any disclosed corporate event. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Indo US Bio-Tech Share Price Today, the key question is how the move fits with valuation, profitability and the Agri sector comparison.
In the first part of Indo US Bio-Tech Share Price News, the data shows a gap between the previous close of Rs 72 and the current trade at Rs 66. That keeps Indo US Bio-Tech Share Price squarely in the day’s lower range and makes the stock a notable mover within the session. The next step is to read the price action alongside the company’s fundamental profile and the Agri industry benchmark.
Indo US Bio-Tech (INDOUS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 66 |
| Previous Close | Rs 72 |
| Today's Move | -Rs 6.00 (-8.33%) |
| Open | Rs 72 |
| High | Rs 72 |
| Low | Rs 65 |
| Market Capitalisation | Rs 144.37 crore |
| Market Cap Category | Micro Cap |
Indo US Bio-Tech Share Price Today reflects a single-session decline of Rs 6, or 8.33%, from the previous close of Rs 72 to Rs 66. The stock opened at Rs 72, touched a high of Rs 72 and a low of Rs 65, which shows that the price action stayed weak after the open. Indo US Bio-Tech Share Price therefore traded near the lower end of the day’s band, with the market capitalisation at Rs 144.37 crore placing it in the Micro Cap category. For readers following Indo US Bio-Tech Share Price live, the important point is that the move was not driven by any stated event inside the numbers; it was a straight price fall visible in the session data.
Indo US Bio-Tech Share Price also matters because the day’s range is relatively tight, moving only between Rs 72 and Rs 65, while the current trade at Rs 66 sits close to the low. In Indi US Bio-Tech Share Price News terms, that is enough to make the stock stand out even without additional context. The next question is whether fundamentals offer support or whether valuation and operating ratios add caution.
Indo US Bio-Tech (INDOUS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 144.37 crore |
| P/E Ratio | 12.6x |
| P/B Ratio | 1.51x |
| ROE | 15.34% |
| ROCE | 14.51% |
| EPS | Rs 5.71 |
| Book Value Per Share | Rs 47.66 |
| Dividend Yield | 0% |
Indo US Bio-Tech (INDOUS) fundamental metrics show P/E 12.6x, P/B 1.51x, ROE 15.34%, ROCE 14.51%. These figures provide context only and are not a buy or sell signal.
Indo US Bio-Tech has a market capitalisation of Rs 144.37 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 12.6x, P/B at 1.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.34% and ROCE of 14.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.71, book value per share of Rs 47.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 14.49x, median ROE of 9.57%, median ROCE of 11%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Agri |
| Industry | Agriculture |
| Benchmark Scope | same industry |
| Company P/E Ratio | 12.6x |
| Benchmark Median P/E | 14.49x |
| Benchmark Average P/E | 55x |
| Benchmark P/E Range | 1.22x to 515.65x |
| Company P/B Ratio | 1.51x |
| Benchmark Median P/B | 1.46x |
| Benchmark Average P/B | -15.43x |
| Company ROE | 15.34% |
| Benchmark Median ROE | 9.57% |
| Benchmark Average ROE | 4.18% |
| Company ROCE | 14.51% |
| Benchmark Median ROCE | 11% |
| Benchmark Average ROCE | 4.98% |
| Company Market Capitalisation | Rs 144.37 crore |
| Benchmark Median Market Cap | Rs 83.46 crore |
| Benchmark Average Market Cap | Rs 491.31 crore |
Indo US Bio-Tech (INDOUS) operates in the Agri sector, within the Agriculture industry.
Indo US Bio-Tech (INDOUS) has a P/E ratio of 12.6x, which is below the benchmark median of 14.49x, a difference of -13.04%. On its own, the P/E gap is a valuation reference point, not a trading call.
Indo US Bio-Tech (INDOUS) has a ROE of 15.34%, which is above the benchmark median of 9.57%, a difference of +60.29%. Indo US Bio-Tech (INDOUS) has a ROCE of 14.51%, which is above the benchmark median of 11%, a difference of +31.91%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Bombay Burmah Trading Corporation | BBTC | 8,578.46 | 6.65 | 1.12 | 39.44 | 44.26 |
| Kaveri Seed Company | KSCL | 3,763.28 | 15.08 | 1.85 | 18.17 | 18.8 |
| Venky'S (India) | VENKEYS | 2,428.94 | 14.01 | 1.48 | 9.07 | 11.92 |
| AVT Natural Products | AVTNPL | 1,518.58 | 18.12 | 2.57 | 12.16 | 14.26 |
| Bombay Super Hybrid Seeds | BSHSL | 1,005.93 | 34.92 | 6.79 | 22.62 | 16.02 |
Indo US Bio-Tech (INDOUS) has a P/E ratio of 12.6x compared with the displayed peer median of 15.08x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 15.34% compares with a peer median of 18.17% across the companies shown in the table. ROCE stood at 14.51% versus the displayed peer median of 16.02%, providing a capital-efficiency comparison. Indo US Bio-Tech (INDOUS) has a market capitalisation of Rs 144.37 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Indo US Bio-Tech
- Indo US Bio-Tech Share Price fell 8.33% to Rs 66, making the latest trade action the first thing investors see today.
- The stock moved from a previous close of Rs 72 and stayed between Rs 72 and Rs 65, which keeps Indo US Bio-Tech Share Price in focus.
- P/E of 12.6 is below the same-industry median of 14.49, which gives Indo US Bio-Tech Share Price valuation context.
- ROE of 15.34% and ROCE of 14.51% are above the sector medians, which supports the fundamental discussion around Indo US Bio-Tech Share Price.
- Market capitalisation of Rs 144.37 crore places the stock in the Micro Cap category and helps frame Indo US Bio-Tech Share Price News.
About Indo US Bio-Tech
Indo US Bio-Tech operates in the Agri sector and the Agriculture industry. For readers tracking Indo US Bio-Tech Share Price, that means the business is part of a segment where valuation and returns often vary sharply across listed companies. The latest UniVest data identifies the company through its market-cap profile, return ratios and sector placement rather than through any separate operating disclosure. Indo US Bio-Tech Share Price therefore needs to be read as an Agriculture-sector stock with measurable profitability ratios and a Micro Cap market value, which helps explain why it appears in stock news coverage today.
Track Indo US Bio-Tech Share Price on Univest
Use Indo US Bio-Tech (INDOUS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Indo US Bio-Tech Share Price on Univest for live updates, valuation ratios, market capitalisation, 52-week levels and market insights in one place. The platform also helps users compare Indo US Bio-Tech Share Price with sector peers and review stock news, financial analysis and stock performance without switching between multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Indo US Bio-Tech Share Price falling today?
Ans. Indo US Bio-Tech Share Price fell 8.33% to Rs 66 from Rs 72. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is visible in today’s opening, high and low.
What is Indo US Bio-Tech Share Price Today?
Ans. Indo US Bio-Tech Share Price Today is Rs 66. The stock opened at Rs 72, touched a high of Rs 72 and a low of Rs 65, which places the current trade near the lower end of the day’s range.
What is the market capitalisation of Indo US Bio-Tech Share Price?
Ans. Indo US Bio-Tech Share Price has a market capitalisation of Rs 144.37 crore. The company is classified as a Micro Cap, so its size context is smaller than many listed agri peers, even though its ratios remain measurable.
How does Indo US Bio-Tech Share Price compare with the Agri sector benchmark?
Ans. Indo US Bio-Tech Share Price has a P/E of 12.6 versus the same-industry median of 14.49 and ROE of 15.34% versus the benchmark median of 9.57%. Its P/B of 1.51 is close to the benchmark median of 1.46.
What do EPS and book value show for Indo US Bio-Tech Share Price?
Ans. EPS is Rs 5.71 and book value is Rs 47.66 per share. These numbers help explain Indo US Bio-Tech Share Price by showing earnings attributed to each share and the accounting net worth backing each share.
Does Indo US Bio-Tech Share Price offer a dividend yield?
Ans. The dividend yield is 0. That means Indo US Bio-Tech Share Price is not carrying a payout yield in the figures currently reflected, so the investment case rests more on valuation and operating ratios.
What does the ROE and ROCE profile say about Indo US Bio-Tech Share Price?
Ans. ROE is 15.34% and ROCE is 14.51%. For Indo US Bio-Tech Share Price, both ratios are above the same-industry medians, which gives the stock a stronger return profile than the typical Agriculture benchmark.
How does Indo US Bio-Tech Share Price look versus peers?
Ans. Indo US Bio-Tech Share Price has a lower market cap than Bombay Burmah Trading Corporation, Kaveri Seed Company and Venky’s (India) Its P/E is also below Kaveri Seed and AVT Natural Products, while ROE remains competitive.
Where can investors track Indo US Bio-Tech Share Price updates?
Ans. Investors can track Indo US Bio-Tech Share Price on Univest for live price updates, ratio snapshots, peer comparisons and sector context. That makes it easier to follow Indo US Bio-Tech Share Price News and compare it with the Agri universe.
